
    
      The success rate of the standard triple therapy for H. pylori infection is decreasing
      recently.Fluoroquinolone has been proposed to replace clarithromycin as an alternative in the
      treatment. However prevalence of H.pylori resistance to Levofloxacin has increased rapidly in
      our area. The purpose of this study is to observe the efficacy of 14 day Levofloxacin triple
      therapy-based, bismuth-containing quadruple therapy for H.pylori treatment.
    
  